Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor
Cerva, C., Colagrossi, L., Maffongelli, G., Salpini, R., Di Carlo, D., Malagnino, V., Battisti, A., Ricciardi, A., Pollicita, M., Bianchi, A., Picardi, A., Cudillo, L., Cerretti, R., Angelis, G.De, CaLangue:
english
Journal:
Clinical Microbiology and Infection
DOI:
10.1016/j.cmi.2016.07.021
Date:
July, 2016
Fichier:
PDF, 375 KB
english, 2016
File converter
Plus de résultats de recherche
More benefits 
